KA Imaging’s Flat Panel Sight™ Receives Medical Device Licence from Health Canada

April 13, 2021

Ka Imaging

KA Imaging’s Flat Panel Sight™ has received a Canadian Medical Device Licence from Health Canada. With the license, the X-ray detector can be officially sold in Canada.

Among its main features, Sight™ can be called featherweight, as it weighs only 2.7 kilos in its 38 X 46cm version and 3.2 kilos in its 46 X 46cm version. In addition, Sight has a Wi-Fi option with a two-second image transfer. It is also IPX6 rated for water. AED allows use with any system.

“Sight™ is a powerful and affordable solution in the medical and veterinary fields”, says Karim S Karim, CTO of KA Imaging. “It is a product that came to complement KA’s line of solutions, so we can better address the different needs of radiologists, considering both technological and financial aspects,” says Amol Karnick, President and CEO of KA Imaging.

 

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.